She has a bachelors degree with honors in architectural sciences from Harvard College and an MBA degree with honors in finance and international business from New York University. Presently, she is a retired Wall Street energy analyst and an advocate for better treatments and increased government funding for ME/CFS.
In July, 1989, she became sick with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) following a flu-like illness. She has had several partial remissions and relapses. One partial remission was for nine months following a round of tetracycline in 1990. Another partial remission was from 1992 to 2003, which she credits to a combination of pharmaceuticals, including amantadine, thyroid hormones, Pemoline, and Wellbutrin. In September, 2003, she relapsed to being bedbound. In 2005, she started IV ozone treatments, which would improve her health, but every time she stopped, she would relapse. She has urged the Chronic Fatigue Syndrome Advisory Committee for the U.S. Department of Health and Human Services to investigate IV ozone therapy.
Talks and interviews[edit | edit source]
- 2012, Episode 37 - Deborah Waroff's testimony at Oct 2012 CFSAC meeting
- 2012, Episode 35 - ME/CFS Alert - Patient Perspectives - Deborah Waroff
- 2014, Episode 71 - Deborah Waroff Speaks Out
HHS/CFSAC Testimony[edit | edit source]
- CFSAC August 2015 Public Comment
- CFSAC January 2015 Public Testimony
- CFSAC October 30, 2009 Public Testimony
Presence Online[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
Chronic Fatigue Syndrome Advisory Committee (CFSAC) - (sometimes pronounced SIF-SACK) A US government advisory council that met twice per year, covering current topics related to Myalgic Encephalomyelitis/Chronic Fatigue Syndrome. Meetings usually lasted for two days and the results were presented to the Secretary of Health and Human Services (HHS). After 15 years, on September 5, 2018, CFSAC's charter was not renewed by the Department of HHS, effectively dissolving the committee without notice or warning.